The global oncology sector features numerous massive pharmaceutical enterprises and specialized biotechnology firms dedicated to developing cancer therapeutics. Prominent industry leaders include multinational giants such as Merck & Co., Roche, Novartis, Pfizer, AstraZeneca, and Bristol Myers Squibb, alongside dedicated oncology specialists and targeted therapy innovators that drive cutting-edge research in cellular immunotherapy and precision medicine.